Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Zidovudine and Lamivudine Tablets

Approval Number

国药准字H20113129

Company安徽贝克生物制药有限公司

Registration Date

January 8, 2021

Previous Approval Numbers

国药准字H20113129

Drug Information

Generic Name

齐多拉米双夫定片

Brand Name

贝拉齐

Dosage Form

片剂

Strength

每片含齐多夫定300mg和拉米夫定150mg

Drug Type

化学药品

Registration Date

January 8, 2021

Company Information

Applicant Company

Company Name安徽贝克生物制药有限公司

Company Address

安徽省合肥市高新技术开发区红枫路30号

Manufacturing Company

Company Name安徽贝克生物制药有限公司

Company Address

合肥市高新技术开发区红枫路30号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy